Stay updated on Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.

Latest updates to the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page revision was updated from v3.4.0 to v3.4.1; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous v3.3.3. This appears to be a minor version update to the page template.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's Locations list was updated with numerous additions and deletions across the United States, Canada, Europe, Australia, and Asia. This changes the study's geographic footprint and which sites are available to potential participants.SummaryDifference3%

- Check90 days agoChange DetectedThe Publications section now clarifies that entries are auto-filled from PubMed and shows updated revision labels (v3.3.2; v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedRemoved the government funding lapse notice that was displayed on the page; there are no changes to study content or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.